Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with a …

Objective Interstitial lung disease (ILD) is one of the most serious complications of rheumatoid
arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept (ABA) in …

Objective This article estimates the incidence and fatality of coronavirus disease 2019 (COVID-19)
and identifies potential risk factors for fatality in patients with active epilepsy. Methods …

Background The susceptibility of patients with rheumatic diseases and the risks or benefits
of immunosuppressive therapies for COVID-19 are unknown. Methods We performed a …

Objective To assess the efficacy of abatacept (ABA) in RA patients with interstitial lung disease
(ILD) (RA-ILD). Methods This was an observational, multicentre study of RA-ILD patients …

Objective To analyze the gut microbiota of patients with rheumatoid arthritis (RA) according
to disease activity. Methods An observational cross-sectional study of 110 patients with RA …

Objective: In this study, we aimed to evaluate the worldwide incidence and prevalence of
ANCA-associated vasculitis (AAV). Methods: A systematic search of Medline and Embase was …

The aim of this study was to evaluate the frequency of response to immunotherapy in patients
with anti‐IgLON5 disease through a systematic review of the literature. MEDLINE and …

Objectives: To describe a prospective cohort of patients with rheumatoid arthritis associated
with interstitial lung disease (RA-ILD) and identify risk factors associated with disease …

This study aimed to identify inflammatory factors and soluble cytokines that act as biomarkers
in the diagnosis and prognosis of rheumatoid arthritis-associated interstitial lung disease (…